Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: A population-based study

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 3, 2008, Pages 243-249

  Chang, L C ^a,c   Huang, N ^a   Chou, Y J ^a   Kao, F Y ^b   Hsieh, P C ^c   Huang, Y T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Bureau of National Health Insurance Taiwan   (Taiwan)

^c Executive Yuan ^*  (Taiwan)

Author keywords

Aspirin; Complementary or alternative medicine; Drug safety; Ginkgo biloba

Indexed keywords

ACETYLSALICYLIC ACID; HYPERICUM PERFORATUM EXTRACT;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CHILD; DRUG SAFETY; HUMAN; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; TAIWAN;

ADULT; AGED; ASPIRIN; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GINKGO BILOBA; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PHYTOTHERAPY; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; PRESCRIPTIONS, DRUG; TAIWAN;

EID: 43049100747     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00911.x     Document Type: Article

References (44)

1. Goldbeck-Wood S, Dorozynski A, Lie LG (1996) Complementary medicine is booming worldwide. British Medical Journal, 313, 131 133.
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of American Medical Association, 280, 1569 1575.
3. Millar WJ (1997) Use of alternative health care practitioners by Canadians. Canadian Journal of Public Health, 88, 154 158.
4. MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet, 347, 569 573.
5. Fisher P, Ward A (1994) Complementary medicine in Europe. British Medical Journal, 309, 107 111.
6. Kessler RC, Davis RB, Foster DF et al. (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Annals of Internal Medicine, 135, 262 268.
7. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Journal of American Medical Association, 287, 337 344.
8. Klepser TB, Doucette WR, Horton MR et al. (2000) Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy, 20, 83 87.
9. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355, 134 138.
10. Izzo AA (2005) Herb-drug interactions: an overview of the clinical evidence. Fundamental and Clinical Pharmacology, 19, 1 15.
11. Boissel J (1998) Individualizing aspirin therapy for prevention of cardiovascular events. Journal of American Medical Association, 280, 1949 1950.
12. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal, 324, 71 86.
13. The Medical Research Council's General Practice Research Framework (1998) Thrombosis prevention trial: randomized trial of low intensity oral anticoagulation with warfarin and low dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet, 351, 233 241.
14. Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet, 351, 1755 1762.
15. He J, Whelton PK, Vu B, Klag MJ (1998) Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. Journal of American Medical Association, 280, 1930 1935.
16. Rodondi N, Vittinghoff E, Cornuz J et al. (2005) Aspirin use for the primary prevention of coronary heart disease in older adults. American Journal of Medicine, 118, 1288 e1 1288 e9.
17. Manes C, Giacci L, Sciartilli A, D'Alleva A, De Caterina R (2006) Aspirin overprescription in primary cardiovascular prevention. Thrombosis Research, 118, 471 477.
18. Matthews MK Jr. (1998) Association of Ginkgo biloba with intracerebral hemorrhage. Neurology, 50, 1933 1934.
19. Ernst E, Pittler MH (1999) Ginkgo biloba for dementia: a systematic review of double-blind, placebo-controlled trials. Clinical Drug Investigation, 17, 301 308.
20. Pittler MH, Ernst E (2000) Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. American Journal of Medicine, 108, 276 281.
21. Moher D, Pham B, Ausejo M, Saenz A, Hood S, Barber GG (2000) Pharmacological management of intermittent claudication: a meta-analysis of randomized trials. Drugs, 59, 1057 1070.
22. Ernst E, Stevinson C (1999) Ginkgo biloba for tinnitus: a review. Clinical Otolaryngology, 24, 164 167.
23. De Smet PAGM (2002) Herbal remedies. New England Journal of Medicine, 347, 2047 2057.
24. Izzo AA, Di Carlo G, Borrelli F, Ernst E (2005) Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. International Journal of Cardiology, 98, 1 14.
25. Bebbington A, Kulkarni R, Roberts P (2005) Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. Journal of Arthroplasty, 20, 125 126.
26. Ang-Lee MK, Moss J, Yuan CS (2001) Herbal medicines and perioperative care. Journal of American Medical Association, 286, 208 216.
27. Mashour NH, Lin GI, Frishman WH (1998) Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Achieves of Internal Medicine, 158, 2225 2234.
28. Boniel T, Dannon P (2001) The safety of herbal medicines in the psychiatric practice. Harefuah, 140, 780 783.
29. Hu Z, Yang X, Ho PC et al. (2005) Herb-drug interactions: a literature review. Drugs, 65, 1239 1282.
30. Lu JF, Hsiao WC (2003) Dose universal health insurance make healthcare unaffordable? Lessons from Taiwan. Health Affairs, 22, 77 88.
31. Cheng TM (2003) Taiwan's new National Health Insurance Program: genesis and experience so far. Health Affairs, 22, 61 76.
32. Chang HJ, Huang N, Lee CH, Hsu YJ, Chou YJ (2004) The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. American Journal of Public Health, 94, 562 564.
33. Huang N, Chou YJ, Chang HJ, Ho M, Morlock L (2005) Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach. Family Practice, 22, 160 167.
34. Yang NP, Deng CY, Chou YJ, Chen PQ, Lin CH, Chou P, Chang HJ (2006) Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy, 75, 329 337.
35. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA (2005) Recent trends in use of herbal and other natural products. Achieves of Internal Medicine, 165, 281 286.
36. Winslow LC, Kroll DJ (1998) Herbs as medicines. Achieves of Internal Medicine, 158, 2192 2199.
37. Fuster V, Chesebro JH (1995) Aspirin for primary prevention of coronary disease. European Heart Journal, 16 (Suppl. E 16 20.
38. Soumerai SB, Ross-degnan D, Kahn JS (1992) Effects of professional and media warnings about the association between aspirin use in children and Reye's syndrome. Milbank Quarterly, 70, 155 182.
39. Köhler S, Funk P, Kieser M (2004) Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagulation and Fibrinolysis, 15, 303 309.
40. Halila M, Cankurtarana M, Yavuza BB (2005) No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment. Blood Coagulation and Fibrinolysis, 16, 349 353.
41. ® provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily? Drugs Research and Development, 7, 163 172.
42. Aruna D, Naidu MUR (2007) Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. British Journal of Clinical Pharmacology, 63, 333 338.
43. Rosenblatt M, Mindel J (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. New England Journal of Medicine, 336, 1108.
44. De Smet PAGM (2007) Clinical risk management of herb-drug interactions. British Journal of Clinical Pharmacology, 63, 258 267.